Candesartan attenuates Angiotensin II-induced mesangial cell apoptosis via TLR4/MyD88 pathway

Biochem Biophys Res Commun. 2009 Feb 27;380(1):81-6. doi: 10.1016/j.bbrc.2009.01.035. Epub 2009 Jan 20.

Abstract

Angiotensin II (Ang II) can stimulate Toll-like receptor 4 (TLR4) expression in mesangial cells (MCs), but the role of TLR4 in the Ang II-induced apoptosis and the effect of candesartan on TLR4 expression remain unclear. Here, we report that Ang II-induced MC apoptosis in a time-dependent manner and up-regulated TLR4/MyD88 expression, and that the intracellular ROS was subsequently increased. We also show that candesartan attenuated the Ang II-induced MC apoptosis, and that this protective effect was dependent on decreased TLR4/MyD88 expression as well as reduced intracellular ROS formation. Furthermore, Ang II increased the apoptosis inducing factor protein level, while candesartan markedly reduced this increase. These results demonstrate that TLR4/MyD88 pathway was involved in the Ang II promoted MC apoptosis, which was related to TLR4/MyD88 mediated oxidative stress. These data also suggest that candesartan exerted anti-apoptotic effect as an antioxidant by modulating this pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin II / antagonists & inhibitors*
  • Angiotensin II / pharmacology
  • Angiotensin II / physiology
  • Animals
  • Antioxidants / pharmacology*
  • Apoptosis / drug effects*
  • Benzimidazoles / pharmacology*
  • Biphenyl Compounds
  • Cell Line
  • Mesangial Cells / drug effects*
  • Myeloid Differentiation Factor 88 / metabolism*
  • Oxidative Stress / drug effects
  • Rats
  • Reactive Oxygen Species / metabolism
  • Tetrazoles / pharmacology*
  • Toll-Like Receptor 4 / agonists
  • Toll-Like Receptor 4 / metabolism*

Substances

  • Antioxidants
  • Benzimidazoles
  • Biphenyl Compounds
  • Myeloid Differentiation Factor 88
  • Reactive Oxygen Species
  • Tetrazoles
  • Toll-Like Receptor 4
  • Angiotensin II
  • candesartan